| dbo:abstract
|
- Arno Gunther Motulsky (5 July 1923 – 17 January 2018) was a professor of medical genetics and genome sciences at the University of Washington. Through his research, writing and mentoring, he helped create and define the field of medical genetics. He is also known as the "father of pharmacogenomics" (the study of how drug action and metabolism differ among people due to genetic variability) based on his report in 1957 of negative drug responses in some patients depending upon their genetics at critical enzymes.[2] Dr. Motulsky joined the faculty at the University of Washington School of Medicine in 1953. In 1957 he founded The Division of Medical Genetics at the University of Washington in 1957. Over his career Dr. Motulsky made many significant contributions to research, patient care and education in human genetics. He was noted for his work on blood diseases, the heritability of lipid disorders, the role of genetic variation in disease, and genetic reasons why people differ in their responses to medications and environmental substances. (en)
- Arno Gunther Motulsky (* 5. Juli 1923 in Fischhausen, Ostpreußen; † 17. Januar 2018 in Seattle) war ein deutsch-amerikanischer Arzt, Genetiker und Mitbegründer der Pharmakogenetik. Von 1959 bis zu seiner Pensionierung war er Direktor der Klinik für Genetik an der University of Washington in Seattle. In einem Nachruf in der New York Times wurde der Direktor der US-amerikanischen National Institutes of Health, Francis Collins, mit den Worten zitiert: „Der Zusammenhang zwischen Vererbung und dem Ansprechen auf Arzneimittel-Therapie, darüber hat niemand nachgedacht bis er vor 60 Jahren damit begonnen hat.“ (de)
|
| dbo:academicAdvisor
| |
| dbo:almaMater
| |
| dbo:award
| |
| dbo:birthDate
| |
| dbo:birthPlace
| |
| dbo:deathDate
| |
| dbo:deathPlace
| |
| dbo:institution
| |
| dbo:knownFor
| |
| dbo:notableStudent
| |
| dbo:thumbnail
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 17106 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:academicAdvisors
| |
| dbp:almaMater
| |
| dbp:awards
| |
| dbp:birthDate
| |
| dbp:birthPlace
| |
| dbp:citizenship
| |
| dbp:deathDate
| |
| dbp:deathPlace
|
- Seattle, Washington, U.S. (en)
|
| dbp:fields
|
- Human genetics, Phamacogenetics (en)
|
| dbp:knownFor
| |
| dbp:name
| |
| dbp:nationality
| |
| dbp:notableStudents
| |
| dbp:spouse
| |
| dbp:wikiPageUsesTemplate
| |
| dbp:workplaces
| |
| dcterms:subject
| |
| gold:hypernym
| |
| schema:sameAs
| |
| rdf:type
| |
| rdfs:comment
|
- Arno Gunther Motulsky (* 5. Juli 1923 in Fischhausen, Ostpreußen; † 17. Januar 2018 in Seattle) war ein deutsch-amerikanischer Arzt, Genetiker und Mitbegründer der Pharmakogenetik. Von 1959 bis zu seiner Pensionierung war er Direktor der Klinik für Genetik an der University of Washington in Seattle. In einem Nachruf in der New York Times wurde der Direktor der US-amerikanischen National Institutes of Health, Francis Collins, mit den Worten zitiert: „Der Zusammenhang zwischen Vererbung und dem Ansprechen auf Arzneimittel-Therapie, darüber hat niemand nachgedacht bis er vor 60 Jahren damit begonnen hat.“ (de)
- Arno Gunther Motulsky (5 July 1923 – 17 January 2018) was a professor of medical genetics and genome sciences at the University of Washington. Through his research, writing and mentoring, he helped create and define the field of medical genetics. He is also known as the "father of pharmacogenomics" (the study of how drug action and metabolism differ among people due to genetic variability) based on his report in 1957 of negative drug responses in some patients depending upon their genetics at critical enzymes.[2] (en)
|
| rdfs:label
|
- Arno Motulsky (en)
- Arno Motulsky (de)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
| |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
